1 In June 2025, the MHRA reinforced this in a public safety update, advising that GLP-1 medicines (a class of weight management and diabetes medications that includes Wegovy, Mounjaro, and Ozempic) must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding
Choosing easily digestible foods in smaller amounts works better with this slower digestive process
Putting the side-effects aside, the earlier reports are showing good but limited amount of weight loss
Retatrutide is at least 18 months away from MHRA approval, and probably longer before its available on the NHS
In addition, the body also needs sufficient magnesium to produce glutathione
Many patients also forget to increase water consumption proportionally to their medication dose, further concentrating stool and worsening constipation